RE:rbc update wow scripts... all up againThis looks very encouraging particularly with respect to Donnatal.
fundtrader wrote: Plaquenil AG TRx up 3.9% WoW, underperforms broader market. Plaquenil AG (Prasco) TRx were up 3.9% WoW vs. down 4.1% the prior week. Total hydroxychloroquine (broader plaquenil market) TRxs were up 5.4% WoW and Prasco's market share (Concordia AG) currently sits at 38.5% of TRx vs. 39.1% the prior week. We have outlined Plaquenil/ hydroxychloroquine market share trends in Exhibit 2.
Lanoxin AG TRx up 1.0% WoW. Par's (AG) market share was up slightly to 31.1% from 30.9%. The Lanoxin AG (Par Pharma) saw TRx increase 1.0% WoW vs. a 5.4% decrease last week. The broader market saw TRx increase 0.2% WoW. We have outlined Lanoxin/Digoxin market trends in Exhibit 3.
Donnatal TRx up 16.9% WoW. Donnatal NRx were up 22.0% WoW vs. down 19.0% the prior week and TRx were up 16.9% WoW vs. down 14.5% the prior week. Donnatal's current market share (TRx) is 1.7%. As previously noted, Donnatal scripts have seen weakness in the face of Allergan’s Viberzi launch (TRx up 14.9% WoW), however Donnatal TRx may have finally stabilized and we will continue to monitor. Exhibit 5 shows Donnatal weekly script trends.